These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

226 related articles for article (PubMed ID: 32101058)

  • 21. [Synchronous primary-multiple cancer of the kidney, urinary bladder and prostate gland].
    Vorob'ev AV; Bystrova VV; Kolomoĭtsev SV; Rozova SL
    Vopr Onkol; 1989; 35(10):1256-7. PubMed ID: 2596074
    [No Abstract]   [Full Text] [Related]  

  • 22. Quantitative light microscopy in urological oncology.
    van der Poel HG; Schaafsma HE; Vooijs GP; Debruyne FM; Schalken JA
    J Urol; 1992 Jul; 148(1):1-13. PubMed ID: 1613843
    [No Abstract]   [Full Text] [Related]  

  • 23. [Sarcomatoid carcinoma of the urinary tract: clinical analysis of 16 cases].
    Zhou C; Xie LP; Zheng XY
    Zhonghua Zhong Liu Za Zhi; 2011 Aug; 33(8):634-5. PubMed ID: 22325229
    [No Abstract]   [Full Text] [Related]  

  • 24. Current status of chemotherapy sensitivity testing for urological malignancies.
    Chin JL; Slocum HK; Bulbul MA; Rustum YM
    J Urol; 1986 Sep; 136(3):555-60. PubMed ID: 3525862
    [No Abstract]   [Full Text] [Related]  

  • 25. Urologic cancer in China.
    Pang C; Guan Y; Li H; Chen W; Zhu G
    Jpn J Clin Oncol; 2016 Jun; 46(6):497-501. PubMed ID: 27049022
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Pathomics in urology.
    Schuettfort VM; Pradere B; Rink M; Comperat E; Shariat SF
    Curr Opin Urol; 2020 Nov; 30(6):823-831. PubMed ID: 32881725
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Synchronous triple urogenital cancer (renal cancer, bladder cancer, prostatic cancer): a case report].
    Takada T; Honda M; Momohara C; Komori K; Fujioka H
    Hinyokika Kiyo; 2002 Apr; 48(4):239-42. PubMed ID: 12048939
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Urologic Pathology: Key Parameters from a Urologist's Perspective.
    Borchert A; Rogers CG
    Surg Pathol Clin; 2018 Dec; 11(4):893-901. PubMed ID: 30447847
    [TBL] [Abstract][Full Text] [Related]  

  • 29. News in the classification of WHO 2022 bladder tumors.
    Raspollini MR; Comperat EM; Lopez-Beltran A; Montironi R; Cimadamore A; Tsuzuki T; Netto GJ
    Pathologica; 2022 Feb; 115(1):32-40. PubMed ID: 36704871
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Grading of renal cell carcinoma.
    Delahunt B; Eble JN; Egevad L; Samaratunga H
    Histopathology; 2019 Jan; 74(1):4-17. PubMed ID: 30565310
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Cultivation of urologic and male genital tumor cells].
    Liu CJ; Wang ZQ; Chang JW; Zhang X; Liu XB; Liu CN; Ma TX
    Zhonghua Zhong Liu Za Zhi; 1986 May; 8(3):178-80. PubMed ID: 3743344
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Biopsy of lesions of the male genitourinary tract.
    Uzzo RG; Vaughan ED
    Surg Oncol Clin N Am; 1995 Jan; 4(1):137-56. PubMed ID: 7697454
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Nuclear p53 overexpression in bladder, prostate, and renal carcinomas.
    Sinik Z; Alkibay T; Ataoglu O; Biri H; Sözen S; Deniz N; Karaoglan U; Bozkirli I
    Int J Urol; 1997 Nov; 4(6):546-51. PubMed ID: 9477181
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The 2014 International Society of Urological Pathology (ISUP) Consensus Conference on Gleason Grading of Prostatic Carcinoma: Definition of Grading Patterns and Proposal for a New Grading System.
    Epstein JI; Egevad L; Amin MB; Delahunt B; Srigley JR; Humphrey PA;
    Am J Surg Pathol; 2016 Feb; 40(2):244-52. PubMed ID: 26492179
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A combination of semiquantitative telomerase assay and in-cell telomerase activity measurement using exfoliated urothelial cells for the detection of urothelial neoplasia.
    Ohyashiki K; Yahata N; Ohyashiki JH; Iwama H; Hayashi S; Ando K; Aizawa T; Ito T; Miki M; Ebihara Y
    Cancer; 1998 Dec; 83(12):2554-60. PubMed ID: 9874463
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Possible role of FDG-PET in the evaluation of urologic malignancies.
    Bender H; Schomburg A; Albers P; Ruhlmann J; Biersack HJ
    Anticancer Res; 1997; 17(3B):1655-60. PubMed ID: 9179213
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Updates in Pathologic Staging and Histologic Grading of Renal Cell Carcinoma.
    Taneja K; Williamson SR
    Surg Pathol Clin; 2018 Dec; 11(4):797-812. PubMed ID: 30447842
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Assessment of the human tumor cloning assay for urologic malignancies with special emphasis on bladder cancer.
    Dittrich C; Schmidbauer CP; Havelec L; Lenzhofer R; Breyer S; Porpaczy P; Moser K
    Oncology; 1986; 43(1):40-5. PubMed ID: 3941801
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Villous adenoma of the urinary tract: a lesion frequently associated with malignancy.
    Seibel JL; Prasad S; Weiss RE; Bancila E; Epstein JI
    Hum Pathol; 2002 Feb; 33(2):236-41. PubMed ID: 11957151
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Mucinous adenocarcinoma of the renal pelvis with other two cancers in urologic organs, triple cancer (author's transl)].
    Honma Y; Komatsu H; Mikata N; Kinoshita K; Okeda R
    Nihon Hinyokika Gakkai Zasshi; 1981 Mar; 72(3):355-8. PubMed ID: 6270439
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.